Annual report [Section 13 and 15(d), not S-K Item 405]

STOCKHOLDERS??? DEFICIT (Tables)

v3.25.2
STOCKHOLDERS’ DEFICIT (Tables)
12 Months Ended
Jun. 30, 2025
Equity [Abstract]  
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY

A summary of the Company’s stock option activity during the years ended June 30, 2025 and 2024 is presented below:

 

          Weighted  
    Number of     Average  
    Options     Price Per Share  
Outstanding at June 30, 2023     0.000001     $ 271,980,000,000  
Issued     -       -  
Exercised     -       -  
Expired     -       -  
Outstanding at June 30, 2024     0.000001     $ 271,980,000,000  
Issued     -       -  
Exercised     -       -  
Expired     -       -  
Outstanding at June 30, 2025     0.000001     $ 271,980,000,000  
                 
Exercisable at June 30, 2025     0.000001     $ 271,980,000,000  
Outstanding and Exercisable:                
                 
Weighted average remaining contractual term     3.87          
Weighted average fair value of options granted during the year   $ -          
Aggregate intrinsic value   $ -          
SUMMARY OF WARRANT ACTIVITY

The following table summarizes common stock warrant activity for the years ended June 30, 2025 and 2024:

 

          Weighted  
    Number of     Average  
    Warrants     Price Per Share  
Outstanding at June 30, 2023     0.06     $ 326,400,000  
Issued     250       600  
Exercised     -       -  
Forfeited     -       -  
Expired     -       -  
Outstanding at June 30, 2024     250     $ 1.24  
Issued     -       -  
Exercised     -       -  
Cancelled*     -       -  
Expired     -       -  
Outstanding at June 30, 2025     250     $ 0.01  
                 
Exercisable at June 30, 2025     250     $ 0.01  
Outstanding and Exercisable:                
                 
Weighted average remaining contractual term     1.01          
Aggregate intrinsic value   $ 1,035          

 

* On March 3, 2025, the Company cancelled all the existing warrants (0.0002 Series A warrants, 0.0003 Series B warrants, and 0.0008 Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above).